Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to
Sana Hachem1, Amani Yehya1, Jad El Masri1
1Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon.
Multi-omics approaches significantly advance prostate cancer biomarker discovery. Integrating various data types enhances detection, identifies new targets, and personalizes treatment for better patient outcomes.
Area of Science:
- Oncology
- Genomics
- Biochemistry
Background:
- Prostate cancer is a leading global health concern for men.
- Current diagnostic and therapeutic strategies face limitations due to tumor heterogeneity.
Purpose of the Study:
- To review advancements in prostate cancer biomarker discovery using single-omics and multi-omics.
- To highlight the potential of multi-omics for personalized medicine in prostate cancer.
Main Methods:
- Comprehensive literature review of single-omics and multi-omics studies.
- Integration of genomic, transcriptomic, proteomic, metabolomic, and epigenomic data.
Main Results:
- Multi-omics approaches reveal prostate cancer's molecular heterogeneity.
- Identification of novel biomarkers and therapeutic targets through integrated analyses.
- Enhanced specificity and sensitivity in prostate cancer detection and management.
Conclusions:
- Multi-omics integration offers a holistic understanding of prostate cancer.
- This approach promises to revolutionize prognosis, treatment, and precision medicine.
- Continued research is crucial for clinical application of multi-omics in prostate cancer care.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Genomics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...